Update: Interim Guidance for the Evaluation and Management of Infants With Possible Congenital Zika Virus Infection — United States, August 2016

CDC has updated its interim guidance for U.S. health care providers caring for infants born to mothers with possible Zika virus infection during pregnancy. Laboratory testing is recommended for 1) infants born to mothers with laboratory evidence of Zika virus infection during pregnancy and 2) infants who have abnormal clinical or neuroimaging findings suggestive of congenital Zika syndrome and a maternal epidemiologic link suggesting possible transmission, regardless of maternal Zika virus test results.

Congenital Zika syndrome is a recently recognized pattern of congenital anomalies associated with Zika virus infection during pregnancy that includes microcephaly, intracranial calcifications or other brain anomalies, or eye anomalies, among others. Recommended infant laboratory evaluation includes both molecular (real-time reverse transcription–polymerase chain reaction [rRT-PCR]) and serologic (immunoglobulin M [IgM]) testing. Initial samples should be collected directly from the infant in the first 2 days of life, if possible; testing of cord blood is not recommended.

Download the updated interim guidance.

Resource Type(s)
Health Care Protocol
Topic(s)
Birth Defects
Child Survival
Clinical Guidelines
Diagnostics
Audience(s)
Health Care Workers
Laboratory Workers
Policymakers
Language(s)
English
Country(ies)
United States
Source(s)
Centers for Disease Control and Prevention

Add new comment

Your email address will not be published. Required fields are marked *